Results 31 to 40 of about 8,024,802 (308)

Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study

open access: yesBiomedicines, 2022
The prognosis for patients with penile squamous cell carcinoma metastatic to regional lymph nodes or distant sites remains poor with limited treatment options, especially after the failure of first-line chemotherapy. Clinical trials evaluating the use of
Dalia Kaakour   +3 more
doaj   +1 more source

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors

open access: yesAdvances in Radiation Oncology, 2021
Purpose Stereotactic body radiation therapy (SBRT) has demonstrated clinical benefits for patients with metastatic and/or unresectable cancer. Technical considerations of treatment delivery and nearby organs at risk can limit the use of SBRT in large ...
S. Duriseti   +9 more
semanticscholar   +1 more source

Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations.

open access: yesSeminars in Radiation Oncology, 2023
Progress in biological cancer characterization, targeted systemic therapies and multimodality treatment strategies have shifted the goals of radiotherapy for spinal metastases from short-term palliation to long-term symptom control and prevention of ...
M. Guckenberger   +3 more
semanticscholar   +1 more source

Stereotactic body radiation therapy for sarcoma pulmonary metastases

open access: yesRadiotherapy and Oncology, 2023
Background/Purpose: Stereotactic body radiation therapy (SBRT) is standard for patients with inoperable early-stage NSCLC. We hypothesized that SBRT for sarcoma pulmonary metastases would achieve high rates of local control with acceptable toxicity and ...
E. Lebow   +16 more
semanticscholar   +1 more source

Long‐term outcomes of metastasis‐directed stereotactic body radiation therapy in metastatic nasopharyngeal carcinoma

open access: yesCancer Medicine, 2023
The study aims to evaluate the outcomes of metastasis‐directed stereotactic body radiation therapy (SBRT) in metastatic nasopharyngeal carcinoma (mNPC).
Jiang-Ping Yang   +6 more
semanticscholar   +1 more source

Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features

open access: yesRadiation Oncology, 2022
Background This study was designed to establish radiation pneumonitis (RP) prediction models using dosiomics and/or deep learning-based radiomics (DLR) features based on 3D dose distribution.
Ying Huang   +9 more
semanticscholar   +1 more source

Stereotactic body radiation therapy in hepatocellular carcinoma [PDF]

open access: yesIndian Journal of Medical and Paediatric Oncology, 2020
Gagan Saini
doaj   +2 more sources

Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.

open access: yesJournal of Hepatology, 2020
BACKGROUND & AIMS In this multinational study, we compared the effectiveness of stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA) in HCC patients treated at seven hospitals.
Nalee Kim   +13 more
semanticscholar   +1 more source

Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study

open access: yesRadiology and Oncology, 2021
The aim of the study was to evaluate acute side effects after extremely hypofractionated intensity-modulated radiotherapy (IMRT) with stereotactic body radiation therapy (SBRT) for definitive treatment of prostate cancer patients.
Jorgo Kliton   +5 more
doaj   +1 more source

Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma

open access: yesTechnology in Cancer Research & Treatment, 2020
Purpose: To assess the efficacy and safety of stereotactic body radiation therapy using an abdominal compression technique and modified fractionation regimen (5-10 fractions) in patients with small-sized hepatocellular carcinoma.
Yi-Xing Chen MD, PhD   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy